Alpha Teknova, Inc. (NASDAQ:TKNO - Get Free Report)'s share price gapped up prior to trading on Monday . The stock had previously closed at $9.01, but opened at $9.58. Alpha Teknova shares last traded at $9.43, with a volume of 139,636 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Craig Hallum initiated coverage on shares of Alpha Teknova in a research note on Monday. They issued a "buy" rating and a $12.00 price objective on the stock.
Get Our Latest Stock Analysis on TKNO
Alpha Teknova Trading Up 1.0 %
The company's 50 day moving average price is $8.49 and its 200 day moving average price is $6.58. The company has a market cap of $441.41 million, a price-to-earnings ratio of -11.19 and a beta of 0.34. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73.
Institutional Trading of Alpha Teknova
Several large investors have recently modified their holdings of TKNO. Roubaix Capital LLC bought a new stake in shares of Alpha Teknova during the 3rd quarter worth $2,015,000. Point72 Asset Management L.P. bought a new position in shares of Alpha Teknova during the 3rd quarter worth about $1,483,000. State Street Corp lifted its holdings in shares of Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company's stock worth $371,000 after acquiring an additional 54,700 shares during the period. Geode Capital Management LLC increased its position in shares of Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company's stock worth $911,000 after purchasing an additional 36,914 shares in the last quarter. Finally, Whalen Wealth Management Inc. acquired a new stake in shares of Alpha Teknova during the 4th quarter worth about $240,000. 13.81% of the stock is owned by institutional investors.
About Alpha Teknova
(
Get Free Report)
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
See Also
Before you consider Alpha Teknova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.
While Alpha Teknova currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
